Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,25 USD | +0,93% | +2,20% | -15,36% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 195 mln. 182 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -68 mln. -63,52 mln. | Nettowinst (verlies) 2025 * | -93 mln. -86,88 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 121 mln. 113 mln. | Nettoliquiditeiten 2025 * | 258 mln. 241 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,66
x | K/w-verhouding 2025 * |
-2,06
x | Werknemers | 52 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,87% |
Recentste transcriptie over Acumen Pharmaceuticals, Inc.
1 dag | +0,93% | ||
1 week | +2,20% | ||
Lopende maand | +0,93% | ||
1 maand | -18,95% | ||
3 maanden | +4,50% | ||
6 maanden | +71,05% | ||
Lopend jaar | -15,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01-04-06 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01-04-06 |
Director/Board Member | 55 | 01-04-22 | |
Jeffrey Ives
BRD | Director/Board Member | 73 | 01-05-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
01-05-24 | 3,25 | +0,93% | 195 492 |
30-04-24 | 3,22 | +1,26% | 82 937 |
29-04-24 | 3,18 | +0,32% | 305 274 |
26-04-24 | 3,17 | -0,63% | 140 701 |
25-04-24 | 3,19 | +0,31% | 167 647 |
uitgestelde koers Nasdaq, 01 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,36% | 195 mln. | |
+0,67% | 42,4 mld. | |
+46,73% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,94 mld. | |
-21,66% | 18,96 mld. | |
+29,96% | 12,3 mld. | |
-1,57% | 11,95 mld. | |
+16,03% | 11,32 mld. | |
-4,80% | 11,55 mld. |